1. Final safety data comes in over the next 2-4 weeks 2. Company planning already phase 2 3. Management and major shareholders all increasing their holdings 4. AGN results will show efficacy because inhibiting calcium influx to prevent further brain injury has already been proven by NA-1. NYR has the same major mechanism of action of inhibiting calcium influx but can be dosed multiple times and at the same time it protects the brain it is the only drug in the world to protect the heart at the same time 5. CEO already talking about licencing the drug in the future
29 million market cap will become a 100 million dollar plus drug like its peers and licencing will come. Patience the fundamentals are all there and an exciting future ahead for sure.
NYR Price at posting:
14.5¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)